GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Darwin AG (XTER:7V0) » Definitions » EBIT

Darwin AG (XTER:7V0) EBIT : € Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Darwin AG EBIT?

Darwin AG's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was €3.30 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Darwin AG's annualized ROC % for the quarter that ended in Dec. 2023 was -0.10%. Darwin AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 16.11%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Darwin AG EBIT Historical Data

The historical data trend for Darwin AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Darwin AG EBIT Chart

Darwin AG Annual Data
Trend Dec21 Dec22 Dec23
EBIT
29.58 59.75 3.30

Darwin AG Semi-Annual Data
Dec21 Dec22 Dec23
EBIT 29.58 59.75 3.30

Competitive Comparison of Darwin AG's EBIT

For the Biotechnology subindustry, Darwin AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Darwin AG's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Darwin AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Darwin AG's EV-to-EBIT falls into.


Darwin AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was € Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Darwin AG  (XTER:7V0) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Darwin AG's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2022 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-3.743 * ( 1 - 98.68% )/( (43.907 + 51.748)/ 2 )
=-0.0494076/47.8275
=-0.10 %

where

Invested Capital(Q: Dec. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=223.812 - 8.908 - ( 170.997 - max(0, 10.438 - 214.552+170.997))
=43.907

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=178.898 - 19.979 - ( 107.941 - max(0, 24.78 - 131.951+107.941))
=51.748

Note: The Operating Income data used here is one times the annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Darwin AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2022  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=3.302/( ( (3.938 + max(32.972, 0)) + (4.091 + max(-3.326, 0)) )/ 2 )
=3.302/( ( 36.91 + 4.091 )/ 2 )
=3.302/20.5005
=16.11 %

where Working Capital is:

Working Capital(Q: Dec. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(11.375 + 8.045 + 23.956) - (8.908 + 0 + 1.496)
=32.972

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.617 + 5.952 + 11.607) - (19.979 + 0 + 2.523)
=-3.326

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Darwin AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=/-22.863
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Darwin AG EBIT Related Terms

Thank you for viewing the detailed overview of Darwin AG's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Darwin AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Darwin AG (XTER:7V0) » Definitions » EBIT
Comparable Companies
XTER:HPHA XTER:BNN STU:9DF XTER:MDG1 XTER:T5O OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX SZSE:300122 BGNE ALNY OCSE:GMAB BMRN
Traded in Other Exchanges
7V0:Germany
Address
Brienner Strasse 7, Munich, BY, DEU, D-80333
Website
https://darwin-biotech.com
Darwin AG is a biotechnology company. It is engaged in the field of human genetics. The group also develops and sells personalized dietary supplements and cosmetics. Its brand includes Novodaily; Rootine and Genopedia.

Darwin AG Headlines

No Headlines